Sage Therapeutics CEO: Mental health is integral to returning to work

Sage Therapeutics CEO: Treating Postpartum Depression | Mad Money | CNBCПодробнее

Sage Therapeutics CEO on why its moving to treat depression nextПодробнее

10 Years of 2020 Mom: Barry Green, Sage TherapeuticsПодробнее

Sage CEO Jeff Jonas on depression drug developmentПодробнее

Episodic drugs provide hope for depression sufferersПодробнее

Welcome Remarks & Sponsor Perspective: Sage Therapeutics | Closing the Maternal Mental Health GapПодробнее

Sage Therapeutics UpdateПодробнее

Recovering from Setbacks, Sage Therapeutics to Develop Treatment for PPD & Major Depressive DisorderПодробнее

Sage Therapeutics CEO: Challenging Conventional Wisdom | Mad Money | CNBCПодробнее

Sage Therapeutics slumps, Biogen bouncesПодробнее

From Awareness to Action: Tackling the Brain Health Pandemic | Barry Greene | TEDxBostonПодробнее

Sage Targets June Launch as FDA Approves Postpartum DrugПодробнее

Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling ...Подробнее

Why Finance Must Build Relationships Across the Organization | Kimi Iguchi, CFO, Sage TherapeuticsПодробнее

Managing Your CDMOs - Advice from Steve Collier of Sage TherapeuticsПодробнее

Sage Therapeutics | Gillette OutingПодробнее

Sage Therapeutics (SAGE) Gets FDA APPROVAL for a Depression Drug | WILL THE STOCK SKYROCKET?Подробнее

The mental health system is broken: Cerebral CEOПодробнее

J480 Case Study #1_ Sage Therapeutics PPD CampaignПодробнее